virus-1 antibody was negative. The peripheral smear reported normocytic erythrocytes, normochromic white blood cells, and adequate platelets. Bone marrow study reported no abnormal lymphoid cell infiltration. The whole-body computed tomography showed multiple enlarged axillary, mediastinal, and inguinal lymph nodes without extralymphatic organ involvement. Positron emission scanning also showed hypermetabolic nodes in bilateral thighs, bilateral inguinal, bilateral iliac, and bilateral axillary areas. Ill-defined areas with increased flourodeoxyglucose uptake in the soft tissue of bilateral lower legs and left upper arm were also seen. The final diagnosis was MF T2N1M0 Stage IIA. Although no tumor was found clinically, because the histopathology revealed tumor-like deeper infiltration rather than plaque-type MF, the oncologist suggested treating this case aggressively as stage IIB (T3N1M0) disease.
She was diagnosed in August 2011 and received one course of chemotherapy with the ProMACE regimen. She next received oral psoralen plus ultraviolet A therapy at the out-patient department with improvement ( Figure 1C ). However, chest computed tomography revealed newly found multiple nodules of lung involvement in 
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Dermatologica Sinica j o u r n a l h o m e p a g e : h t t p : / / w w w . d e r m -s i n i c a . c o m patch, plaque, or tumor stages. Poikiloderma as a clinical presentation has also been reported. 1 The diagnosis of GMF can be challenging, because its granulomatous inflammation pattern can be mistaken for other types of granulomatous dermatitis. Sarcoid granuloma patterns are most often found, and granuloma annulare patterns and tuberculoidlike granuloma have also been reported. 2, 3 Other causes of infectious and noninfectious granulomatous disease must be ruled out. CD4-positive GMF is most common, although rare cases of CD8-positive GMF have been reported. 4 Atypical lymphocytes, epidermotropism, Pautrier microabscesses, and dermal fibrosis are common histological findings of classic MF. 5 These findings are also typical features for GMF, but epidermotropism has been found in approximately half of reported GMF cases. 6 Atypical lymphocyte infiltration and clinical correlation are important for differential diagnosis. T-cell receptor gene clonal rearrangement detection may be helpful for diagnosis. However, MF in its granulomatous form can still be difficult to diagnose. A previous study found that the average duration before diagnosis of GMF was longer than for classic MF (8.4 years vs. 4.3 years, respectively). 7 The granulomatous infiltrate pattern has not been found to be a conclusive positive prognostic marker. Initially, a granulomatous reaction was thought to be an immune response reaction and a sign of a better prognosis. However, a caseecontrol study 7 reported more frequent disease progression in granulomatous MF than in classic MF (46% and 30%, respectively). Compared with classic MF, the progression-free rate of GMF was significantly lower at 5-year (84% of classic MF vs. 56% of GMF) and 10-year follow-up (59% of classic MF vs. 33% of GMF). 7 However, no significant difference was found in overall survival. Poorer response to skin-directed therapy was observed in GMF patients versus classic MF patients, and more aggressive treatment may be required for the former. 8 Our patient received one cycle of ProMACE chemotherapy, followed by PUVA therapy. Disease progression with multiple lung nodule involvement was noted 23 months later. In summary, we present a case of GMF, which is rarely reported in Taiwan. Dermatologists should be alert to the possibility of mistaking GMF for other types of granulomatous inflammation infiltrate disease. The prognosis of GMF is controversial, and more study is needed.
